المؤلفون: Albuquerque, João, Antunes, Marília

المساهمون: Antunes, Marília, Bourbon, Mafalda, Soares, Raquel, Repositório Científico do Instituto Nacional de Saúde

مصطلحات موضوعية: Familial Hypercholesterolemia, Logistic Regression, Decision Tree, Ensemble Learn ers, Naive Bayes, Synthetic Minority Over-sampling Technique, Youden Index Maximization, Simon Broome Criteria, Dutch Lipid Clinic Network Criteria, Hipercolesterolemia Familiar, Regressão Logística, Árvore de Decisão, Classicadores Ensemble, Maximização do Índice de Youden, Critérios de Simon Broome, Critérios Dutch Lipid Clinic Network

وصف الملف: application/pdf

الإتاحة: http://hdl.handle.net/10400.18/9164Test

المؤلفون: O. V. Gaisenok, О. В. Гайсёнок

المصدر: Meditsinskiy sovet = Medical Council; № 6 (2023); 22-27 ; Медицинский Совет; № 6 (2023); 22-27 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: электронные базы данных, diagnostics, Dutch Lipid Clinic Network Criteria, Duplex Registry, Laboratory Registry, electronic databases, диагностика, регистр Дуплекс, Лабораторный регистр

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/7478/6667Test; Yusuf S., Rangarajan S., Teo K., Islam S., Li W., Liu L. et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–827. https://doi.org/10.1056/NEJMoa1311890Test.; Bogsrud M.P., Øyri L.K.L., Halvorsen S., Atar D., Leren T.P., Holven K.B. Prevalence of genetically verified familial hypercholesterolemia among young (; Wang Z., Liu W., Jiang L., Wang L., Yu W. The use of high-resolution MRI to detect thrombosis and lipid-rich carotid artery plaques in a patient with homozygous familial hypercholesterolemia. Rev Assoc Med Bras. 2020;66(1):31–35. https://doi.org/10.1590/1806-9282.66.1.31Test.; Hu P., Dharmayat K.I., Stevens C.A.T., Sharabiani M.T.A., Jones R.S., Watts G.F. et al. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis. Circulation. 2020;141(22):1742–1759. https://doi.org/10.1161/CIRCULATIONAHA.119.044795Test.; Akioyamen L.E., Genest J., Shan S.D., Reel R.L., Albaum J.M., Chu A., Tu J.V. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7:e016461. https://doi.org/10.1136/bmjopen-2017-016461Test.; Карпов Ю.А., Кухарчук В.В., Бойцов С.А., Воевода М.И., Гафаров В.В., Гуревич В.С. и др. Заключение совета экспертов Национального общества по изучению атеросклероза (НОА). Семейная гиперхолестеринемия в Российской Федерации: нерешенные проблемы диагностики и лечения. Атеросклероз и дислипидемии. 2015;(2):5–16. Режим доступа: https://jad.noatero.ru/index.php/jad/article/view/135Test.; Elis A., Leventer-Roberts M., Bachrach A., Lieberman N., Durst R., Knobler H., Balicer R. The characteristics of patients with possible familial hypercholesterolemia-screening a large payer/provider healthcare delivery system. QJM. 2020;113(6):411–417. https://doi.org/10.1093/qjmed/hcz327Test.; Alonso R., Perez de Isla L., Muñiz-Grijalvo O., Mata P. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care. Vasc Health Risk Manag. 2020;(16):11–25. https://doi.org/10.2147/VHRM.S192401Test.; Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478–3490. https://doi.org/10.1093/eurheartj/eht273Test.; Wald D.S., Bestwick J.P. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies. Atherosclerosis. 2020;293:57–61. https://doi.org/10.1016/j.atherosclerosis.2019.11.028Test.; Goldberg A.C., Hopkins P.N., Toth P.P., Ballantyne C.M., Rader D.J., Robinson J.G. et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5(3):S1–S8. https://doi.org/10.1016/j.jacl.2011.04.003Test.; Umans-Eckenhausen M.A., Defesche J.C., Sijbrands E.J., Scheerder R.L., Kastelein J.J. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357(9251):165–168. https://doi.org/10.1016/S0140-6736Test(00)03587-X.; Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis. 1999;142(1):105–112. Available at: https://pubmed.ncbi.nlm.nih.gov/9920511Test/.; Corral P., Bañares V., Sáenz B., Zago V., Sarobe A., López G. et al. Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina. Arch Cardiol Mex. 2020;90(2):130–136. https://doi.org/10.24875/ACME.M20000106Test.; Truong T.H., Do D.L., Kim N.T., Nguyen M.T., Le T.T., Le H.A. Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry. Front Genet. 2020;(11):914. https://doi.org/10.3389/fgene.2020.00914Test.; Kellogg G., Thorsson B., Cai Y., Wisotzkey R., Pollock A., Akana M. et al. Molecular screening of familial hypercholesterolemia in Icelanders. Scand J Clin Lab Invest. 2020;80(6):508–514. https://doi.org/10.1080/00365513.2020.1795919Test.; Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97(11):3956–3964. https://doi.org/10.1210/jc.2012-1563Test.; Wald D.S., Martin A.C. Decision to reject screening for familial hypercholesterolaemia is flawed. Arch Dis Child. 2021;106(6):525–526. https://doi.org/10.1136/archdischild-2020-319168Test.; Representatives of the Global Familial Hypercholesterolemia Community, Wilemon K.A., Patel J., Aguilar-Salinas C., Ahmed C.D., Alkhnifsawi M., Almahmeed W. et al. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. JAMA Cardiol. 2020;5(2):217–229. https://doi.org/10.1001/jamacardio.2019.5173Test.; Kose E., Kose M., Ozturk S.I., Ozcan E., Onay H., Ozkan B. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey. J Pediatr Endocrinol Metab. 2020;33(10):1251–1256. https://doi.org/10.1515/jpem-2020-0234Test.; Ежов М.В., Сергиенко И.В., Дупляков Д.В., Абашина О.Е., Качковский М.А., Шапошник И.И. и др. Результаты Российской научно-исследовательской программы по диагностике и лечению больных семейной гиперхолестеринемией. Высокая распространенность, низкая информированность, плохая приверженность. Атеросклероз и дислипидемии. 2017;(2):5–15. Режим доступа: https://jad.noatero.ru/index.php/jad/article/view/197Test; Гайсёнок О.В., Курносов П.А., Леонов А.С., Затейщиков Д.А. Скрининг семейной гиперхолестеринемии среди пациентов в возрасте до 40 лет, подвергнутых дуплексному сканированию cонных артерий, по данным локального регистра. Терапевтический архив. 2018;90(9):37–41. https://doi.org/10.26442/terarkh201890937-41Test.; Gaisenok O., Drapkina O. Gender differences in the detection of carotid atherosclerosis: DUPLEX registry cross-sectional study results. Monaldi Arch Chest Dis. 2022;92(4):2128. https://doi.org/10.4081/monaldi.2022.2128Test.; Гайсёнок О.В., Леонова М.В. Индекс гетерогенности эритроцитов как биомаркер тяжести хронической сердечной недостаточности у пожилых пациентов. Медицинский совет. 2021;(14):134–140. https://doi.org/10.21518/2079-701X-2021-14-134-140Test.; Гайсёнок О.В. Сравнительный анализ вариабельности индекса гетерогенности эритроцитов в зависимости от принадлежности к определенной нозологической группе болезней по классификации МКБ-10. Клиническая лабораторная диагностика. 2020;65(8):487–491. https://doi.org/10.18821/0869-2084-2020-65-8-487-491Test.; Метельская В.А., Шальнова С.А., Деев А.Д., Перова Н.В., Гомыранова Н.В., Литинская О.А. и др. Анализ распространенности показателей, характеризующих атерогенность спектра липопротеинов, у жителей Российской Федерации (по данным исследования ЭССЕ-РФ). Профилактическая медицина. 2016;19(1):15–23. https://doi.org/10.17116/profmed201619115-23Test.; Ершова А.И., Мешков А.Н., Якушин С.С., Лукьянов М.М., Мосейчук К.А., Марцевич С.Ю. и др. Диагностика и лечение больных с выраженной гиперхолестеринемией в реальной амбулаторно-поликлинической практике (по данным регистра Рекваза). Рациональная фармакотерапия в кардиологии. 2014;10(6):612–616. https://doi.org/10.20996/1819-6446-2014-10-6-612-616Test.; Аверкова А.О., Бражник В.А., Королева О.С., Зубова Е.А., Хасанов Н.Р., Иванцов Е.Н. и др. Распространенность семейной гиперлипидемии у больных с ранним развитием острого коронарного синдрома. Кремлевская медицина. Клинический вестник. 2017;(1):103–108. Режим доступа: https://www.elibrary.ru/item.asp?id=28991253Test.; Аверкова А.О., Бражник В.А., Рогожина А.А., Евдокимова М.А., Королева О.С., Сизгунов Д.С. и др. Отягощенная наследственность у больных с «ранним» развитием острого коронарного синдрома. Кардиология. 2018;58(8):12–17. https://doi.org/10.18087/cardio.2018.8.10158Test.; Корнева В.А., Кузнецова Т.Ю., Тихова Г.П. Гиполипидемическая терапия у пациентов с гетерозиготной семейной гиперхолестеринемией. Кардиология. 2019;59(3):27–35. https://doi.org/10.18087/cardio.2019.3.10238Test.; Pajak A., Szafraniec K., Polak M., Drygas W., Piotrowski W., Zdrojewski T., Jankowski P. Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland. Arch Med Sci. 2016;12(4):687–696. https://doi.org/10.5114/aoms.2016.59700Test.; Safarova M.S., Liu H., Kullo I.J. Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study. J Clin Lipidol. 2016;10(5):1230–1239. https://doi.org/10.1016/j.jacl.2016.08.001Test.; Davis J.W., Chung R., Juarez D.T. Prevalence of comorbid conditions with aging among patients with diabetes and cardiovascular disease. Hawaii Med J. 2011;70(10):209–213. Available at: https://pubmed.ncbi.nlm.nih.gov/22162595Test/; https://www.med-sovet.pro/jour/article/view/7478Test

الإتاحة: https://doi.org/10.21518/ms2022-043Test
https://doi.org/10.1056/NEJMoa1311890Test
https://doi.org/10.1016/j.jacl.2020.04.002Test
https://doi.org/10.1590/1806-9282.66.1.31Test
https://doi.org/10.1161/CIRCULATIONAHA.119.044795Test
https://doi.org/10.1136/bmjopen-2017-016461Test
https://doi.org/10.1093/qjmed/hcz327Test
https://doi.org/10.2147/VHRM.S192401Test
https://doi.org/10.1093/eurheartj/eht273Test
https://doi.org/10.1016/j.atherosclerosis.2019.11.028Test

المؤلفون: Albuquerque, João, Medeiros, Ana Margarida, Alves, Ana Catarina, Jannes, Cinthia Elim, Mancina, Rosellina M., Pavanello, Chiara, Chora, Joana Rita, Mombelli, Giuliana, Calabresi, Laura, Pereira, Alexandre da Costa, Krieger, José Eduardo, Romeo, Stefano, Bourbon, Mafalda, Antunes, Marília

مصطلحات موضوعية: Logistic Regression, Dutch Lipid Clinic Network Criteria, Validation, Familial Hypercholesterolaemia, Doenças Cardio e Cérebro-vasculares

العلاقة: info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FMAT%2F00006%2F2019/PT; info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FSAU-SER%2F29180%2F2017/PT; https://www.sciencedirect.com/science/article/pii/S0021915023052358?via%3DihubTest; Atherosclerosis. 2023 Oct:383:117314. doi:10.1016/j.atherosclerosis.2023.117314. Epub 2023 Sep 28.; http://hdl.handle.net/10400.18/8767Test

الإتاحة: https://doi.org/10.1016/j.atherosclerosis.2023.117314Test
http://hdl.handle.net/10400.18/8767Test

المؤلفون: Teresa Arrobas Velilla, Ángel Brea, Pedro Valdivielso

المصدر: Frontiers in Genetics, Vol 13 (2022)

مصطلحات موضوعية: familial hypercholesterolemia (FH), clinical laboratory, lipid units, Dutch lipid clinic network criteria, screening, Genetics, QH426-470

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fgene.2022.971651/fullTest; https://doaj.org/toc/1664-8021Test

الوصول الحر: https://doaj.org/article/a5686cbc0fca4957af28a60747bf7924Test

المؤلفون: Arrobas Velilla, Teresa, Brea, Ángel, Valdivielso, Pedro

مصطلحات موضوعية: Dutch lipid clinic network criteria, clinical laboratory, familial hypercholesterolemia (FH), lipid units, screening

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/20576Test; PMC9465084; https://www.frontiersin.org/articles/10.3389/fgene.2022.971651/pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465084/pdfTest

الإتاحة: https://doi.org/10.3389/fgene.2022.971651Test
http://hdl.handle.net/10668/20576Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465084/pdfTest

المؤلفون: Uliana V. Chubykina, Marat V. Ezhov, Olga I. Afanasieva, Elena A. Klesareva, Sergei N. Pokrovsky

المصدر: Diseases; Volume 10; Issue 1; Pages: 6

مصطلحات موضوعية: lipoprotein(a), familial hypercholesterolemia, Dutch Lipid Clinic Network criteria

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/diseases10010006Test

الإتاحة: https://doi.org/10.3390/diseases10010006Test

المؤلفون: Anna E. Semenova, Igor V. Sergienko, Diego García-Giustiniani, Lorenzo Monserrat, Anna B. Popova, Diana N. Nozadze, Marat V. Ezhov

المصدر: Journal of Cardiovascular Development and Disease; Volume 7; Issue 2; Pages: 16

مصطلحات موضوعية: familial hypercholesterolemia, next generation sequencing, LDLR, Dutch lipid clinic network criteria, cardiovascular risk

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/jcdd7020016Test

الإتاحة: https://doi.org/10.3390/jcdd7020016Test

المؤلفون: Teresa Arrobas Velilla, Ángel Brea, Pedro Valdivielso

مصطلحات موضوعية: Genetics, Genetic Engineering, Biomarkers, Developmental Genetics (incl. Sex Determination), Epigenetics (incl. Genome Methylation and Epigenomics), Gene Expression (incl. Microarray and other genome-wide approaches), Genome Structure and Regulation, Genomics, Genetically Modified Animals, Livestock Cloning, Gene and Molecular Therapy, familial hypercholesterolemia (FH), clinical laboratory, lipid units, Dutch lipid clinic network criteria, screening

العلاقة: https://figshare.com/articles/dataset/DataSheet1_Implementation_of_a_biochemical_clinical_and_genetic_screening_programme_for_familial_hypercholesterolemia_in_26_centres_in_Spain_The_ARIAN_study_DOCX/20707159Test

الإتاحة: https://doi.org/10.3389/fgene.2022.971651.s001Test
https://figshare.com/articles/dataset/DataSheet1_Implementation_of_a_biochemical_clinical_and_genetic_screening_programme_for_familial_hypercholesterolemia_in_26_centres_in_Spain_The_ARIAN_study_DOCX/20707159Test

المؤلفون: Teresa Arrobas Velilla, Ángel Brea, Pedro Valdivielso

مصطلحات موضوعية: Genetics, Genetic Engineering, Biomarkers, Developmental Genetics (incl. Sex Determination), Epigenetics (incl. Genome Methylation and Epigenomics), Gene Expression (incl. Microarray and other genome-wide approaches), Genome Structure and Regulation, Genomics, Genetically Modified Animals, Livestock Cloning, Gene and Molecular Therapy, familial hypercholesterolemia (FH), clinical laboratory, lipid units, Dutch lipid clinic network criteria, screening

العلاقة: https://figshare.com/articles/dataset/Table1_Implementation_of_a_biochemical_clinical_and_genetic_screening_programme_for_familial_hypercholesterolemia_in_26_centres_in_Spain_The_ARIAN_study_DOCX/20707162Test

الإتاحة: https://doi.org/10.3389/fgene.2022.971651.s002Test
https://figshare.com/articles/dataset/Table1_Implementation_of_a_biochemical_clinical_and_genetic_screening_programme_for_familial_hypercholesterolemia_in_26_centres_in_Spain_The_ARIAN_study_DOCX/20707162Test

المؤلفون: I.C. Verma, Rajneesh Jain, Bhuwanesh Kandpal, R.R. Mantri, Rajiv Passey, S.R. Prasad, Arun Mohanty, Aman Makhija, Ashwani Mehta, Kushal Madan, Bhola Shankar Vivek, J.P.S. Sawhney, Manish Sharma, Subhash C. Manchanda

المصدر: Indian Heart Journal
Indian Heart Journal, Vol 71, Iss 2, Pp 118-122 (2019)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Correction factor, RD1-811, Familial hypercholesterolemia, Premature coronary artery disease, India, Coronary Artery Disease, 030204 cardiovascular system & hematology, North india, Hyperlipoproteinemia Type II, Tertiary Care Centers, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Diabetes mellitus, medicine, Prevalence, Diseases of the circulatory (Cardiovascular) system, Humans, 030212 general & internal medicine, Myocardial infarction, Family history, Arcus cornealis, business.industry, Incidence (epidemiology), Dutch Lipid Clinic Network Criteria, Tertiary care hospital, Middle Aged, medicine.disease, RC666-701, Surgery, Original Article, Female, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01922af36799982cdf264ddd0b79e2b9Test
http://europepmc.org/articles/PMC6620422Test